上胸椎T1和T2经皮椎体成形术:10年经验回顾
回顾性纳入2012年3月至2021年9月单中心行T1或T2椎体成形术的40例患者共49个椎体,技术成功(骨针轨迹正确避开椎管且骨水泥终板到终板填充且无不良事件)39/49(79.5%),骨水泥渗漏率84%,按CIRSE分级无不良事件,结论为透视下上胸椎椎体成形术技术上可行且安全。
要点
- T1和T2椎体成形术技术成功率为79.5%(39/49个椎体)。
- 骨针轨迹满意者占91%(73/80次入路),终板到终板填充者占82%。
- 术后对照CT显示骨水泥渗漏率84%,按CIRSE分级无不良事件报告。
核心结论
- 透视引导下上胸椎椎体成形术具有挑战性,但技术上可实现且安全。
- 优化操作流程对克服解剖困难至关重要。
- 即使优化操作,透视引导上胸椎椎体成形术的主要限制仍是侧位透视控制的质量。
研究设计与样本
- 单中心三级教学医院回顾性研究,纳入2012年3月至2021年9月所有行T1或T2椎体成形术的患者,排除无术后对照CT者。
- 共纳入40例患者(女19例,男21例,平均年龄65岁,范围18-89岁),共计49个椎体,其中T1椎体成形术31/49(63%)。
- 49个椎体成形术中30个(61%)用于治疗各种癌症的骨转移。
- 回顾性收集人口学资料、手术指征、椎体成形术节段、骨针位置、手术细节、椎体体积、体内骨水泥体积、并发症(CIRSE评分)及临床随访。
- 主要结局为手术技术成功,定义为骨针轨迹正确避开椎管且骨水泥终板到终板填充,且无任何不良事件。
关键影像表现/征象
- 技术成功(骨针轨迹正确避开椎管且骨水泥终板到终板填充且无不良事件)在49个上胸椎椎体成形术中为39个(79.5%)。
- 骨针轨迹满意在80次入路中为73次(91%)。
- 终板到终板填充在82%的病例中实现。
- 术后对照CT显示84%的病例观察到骨水泥渗漏。
诊断标准与关键数值
- 技术成功定义为骨针轨迹正确避开椎管且骨水泥终板到终板填充,且无任何不良事件,成功率为79.5%(39/49个椎体)。
- 骨针轨迹满意率为91%(73/80次入路);终板到终板填充率为82%。
- 骨水泥渗漏率84%(基于术后对照CT);并发症按CIRSE分类,无不良事件报告。
临床应用与阅片要点
- 透视引导下T1和T2椎体成形术技术上可行且安全,但操作具有挑战性。
- 优化操作流程对克服解剖困难至关重要。
- 侧位透视控制的质量是透视引导上胸椎椎体成形术的主要限制,即使优化操作亦然。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: T1 and T2 upper thoracic vertebroplasties (UTVs) represent a technical challenge due to various anatomical factors that impact the quality of fluoroscopic control and potentially increase procedural risks. The aim of this study is to report the feasibility and safety of T1-T2 UTV.
MATERIALS AND METHOD: All patients having undergone UTV (T1 or T2) from March 2012 to September 2021 in a single tertiary care teaching hospital were included. Patients without a post-procedure control CT scan were excluded. The following data were retrospectively collected: demographics, procedure indications, vertebroplasty level(s), bone needle position, procedure details, vertebral body volume, intracorporeal cement volume, complications (CIRSE score), and clinical follow-up. The primary outcome was procedural technical success, defined as achieving both a correct bone-needle trajectory avoiding the spinal canal and endplate-to-endplate cement filling, without any adverse events.
RESULTS: Forty patients (19 females, 21 males, average age 65 years [range 18-89]) were included, totaling 49 vertebrae with 31/49 (63%) T1 vertebroplasties. Of the 49 UTVs, 30 (61%) were performed to treat bone metastases from various cancers. The primary outcome, technical success, was achieved in 39/49 (79.5%) of the UTVs. Satisfactory bone needle trajectory was reported in 73/80 (91%) of the approaches, and endplate-to-endplate filling was achieved in 82% of cases. Cement leakage was observed on 84% of the post-operative control CT scans. Based on the CIRSE classification, no adverse events were reported.
CONCLUSION: UTV under fluoroscopic control is a challenging procedure, but it is technically achievable and safe. Procedure optimization is paramount to overcoming anatomical difficulties.
KEY POINTS: Question This study aims to report the feasibility and safety of upper thoracic vertebroplasty (UTV) of T1 and T2 vertebrae, a challenging procedure, seldom reported. Findings T1 and T2 UTV is technically feasible and safe under fluoroscopic guidance. Clinical relevance T1 and T2 UTV remains a complex procedure despite demonstrating technical success and a low complication rate. The main limit to fluoroscopy-guided UTV, even with procedure optimization, is the quality of lateral-projection fluoroscopic control.
引用
- Trebern H, Premat K, Chiaroni PM, et al. Upper thoracic T1 and T2 percutaneous vertebroplasty: a review of 10 years of experience. Eur Radiol. 2025. PMID: 40643619. doi:10.1007/s00330-025-11769-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。